Stefan Walenta
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 32
- Molecular Biology top 5%
- Mitochondrial Function and Pathology 8
- bioluminescence and chemiluminescence research 7
- Oncology top 5%
-
- Medical Imaging Techniques and Applications 14
- Biotechnology top 2%
- Cancer Research and Treatments 7
-
- 3D Printing in Biomedical Research 9
- Nanoplatforms for cancer theranostics 7
- Ultrasound and Hyperthermia Applications 7
- Co-authors
- Wolfgang Mueller‐KlieserW. Mueller-KlieserKolbein SundførW. Mueller‐KlieserThies SchroederEinar K. RofstadMichael LehrkeE K Rofstad
- Journals
- International Journal of Oncology (5 papers)Radiotherapy and Oncology (5 papers)Journal of Cancer Research and Clinical Oncology (4 papers)
- Partner nations
- GermanyCzechiaUnited States
In The Last Decade
Stefan Walenta
70 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 2.5k
- Molecular Biology 2.5k
- Oncology 785
- Radiology, Nuclear Medicine and Imaging 618
- Biotechnology 208
Countries citing papers authored by Stefan Walenta
This map shows the geographic impact of Stefan Walenta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Walenta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Walenta more than expected).
Fields of papers citing papers by Stefan Walenta
This network shows the impact of papers produced by Stefan Walenta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Walenta. The network helps show where Stefan Walenta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan Walenta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 6 | |
| 2 | 2016 | 2 | |
| 3 | 2013 | 19 | |
| 4 | 2011 | 32 | |
| 5 | 2011 | 170 | |
| 6 | 2009 | 173 | |
| 7 | 2007 | 7 | |
| 8 | 2006 | 151 | |
| 9 | 2006 | 83 | |
| 10 | 2004 | 15 | |
| 11 | 2004 | 355 | |
| 12 | 2004 | 209 | |
| 13 | 2003 | 55 | |
| 14 | 2003 | 92 | |
| 15 | 2002 | 99 | |
| 16 | 2002 | 71 | |
| 17 | 2001 | 58 | |
| 18 | 1996 | 12 | |
| 19 | 1993 | 12 | |
| 20 | 1989 | 19 |
About Stefan Walenta
Stefan Walenta is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 71 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (32 papers), Medical Imaging Techniques and Applications (14 papers), 3D Printing in Biomedical Research (9 papers), Mitochondrial Function and Pathology (8 papers), bioluminescence and chemiluminescence research (7 papers), Nanoplatforms for cancer theranostics (7 papers), Cancer Research and Treatments (7 papers) and Ultrasound and Hyperthermia Applications (7 papers). The work is most often cited by research in Cancer Research (2.5k citations), Molecular Biology (2.5k citations) and Oncology (785 citations). Stefan Walenta has collaborated with scholars based in Germany, Czechia and United States. Frequent co-authors include Wolfgang Mueller‐Klieser, W. Mueller-Klieser, Kolbein Sundfør, W. Mueller‐Klieser, Thies Schroeder, Einar K. Rofstad, Michael Lehrke, E K Rofstad, David M. Brizel and Mark W. Dewhirst. Their work appears in journals such as International Journal of Oncology, Radiotherapy and Oncology, Journal of Cancer Research and Clinical Oncology, JNCI Journal of the National Cancer Institute and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.